Ligand Pharmaceuticals
LGND
#3462
Rank
โ‚ฌ3.37 B
Marketcap
169,47ย โ‚ฌ
Share price
-4.03%
Change (1 day)
70.44%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of December 2025 : โ‚ฌ0.88 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has โ‚ฌ0.88 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$โ‚ฌ0.86 B8.51%
2024-12-31$โ‚ฌ0.79 B25.86%
2023-12-31$โ‚ฌ0.63 B13.83%
2022-12-31$โ‚ฌ0.55 B-23.18%
2021-12-31$โ‚ฌ0.72 B25.7%
2020-12-31$โ‚ฌ0.57 B-15.77%
2019-12-31$โ‚ฌ0.68 B39.68%
2018-12-31$โ‚ฌ0.49 B40.52%
2017-12-31$โ‚ฌ0.34 B-1.04%
2016-12-31$โ‚ฌ0.35 B39.22%
2015-12-31$โ‚ฌ0.25 B1161.93%
2014-12-31$โ‚ฌ20.06 M-44.14%
2013-12-31$โ‚ฌ35.92 M79.43%
2012-12-31$โ‚ฌ20.02 M217.68%
2011-12-31$โ‚ฌ6.3 M-272.89%
2010-12-31$-โ‚ฌ3.65 Million-239.5%
2009-12-31$โ‚ฌ2.61 M-135.25%
2008-12-31$-โ‚ฌ7.42 Million-137.18%
2007-12-31$โ‚ฌ19.94 M-3.81%
2006-12-31$โ‚ฌ20.72 M-122.24%
2005-12-31$-โ‚ฌ93.22 Million67.88%
2004-12-31$-โ‚ฌ55.53 Million86.14%
2003-12-31$-โ‚ฌ29.83 Million-142.13%
2002-12-31$โ‚ฌ70.8 M-208.04%
2001-12-31$-โ‚ฌ65.54 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ70.69 B 7,916.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ75.22 B 8,430.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ23.00 B 2,508.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.50 B 751.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ5.28 B 499.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ45.65 B 5,077.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ16.04 B 1,719.29%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ18.62 B 2,012.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
โ‚ฌ23.23 M-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA